Gene Therapy Drug Pipeline Analysis

Gene Therapy Drug Pipeline Analysis by PNS Pharma gives comprehensive insight on the
various drugs being developed for the treatment of multiple disease based upon Gene
Therapy. Research report covers all the ongoing drug development in various development
phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator,
Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of
Action, Country of Development and detailed analysis on the development process. Insight for
each drug profile in development phase enables the reader to identify and understand the
Gene Therapy associated with the various diseases.
This report enables pharmaceutical companies, collaborators and other associated stake
holders to identify and analyze the available investment opportunity in the Gene Therapy
based drug development process.
For Report Sample Contact: rajesh@pnspharma.com
Following parameters for each drug profile in development phase are covered in Gene
Therapy Drug Pipeline Analysis research report:
Drug Profile Overview
Alternate Names for Drug
Active Indication Phase of Development
Mechanism of Action
Country for Clinical Trial
Owner / Originator/ Licensee/Collaborator
Administrative Route
Drug Class
ATC Codes
Number of Drug Profiles in Development Phases:
Research: 4
Preclinical: 49
Phase I: 22
Phase I/II: 14
Phase II: 22
Phase III: 2
Preregistration: 1
Registered: 1
Marketed: 1
For Report Sample Contact: rajesh@pnspharma.com
Each Drug Profile has Tables Representing Following Information:
Alternate Names
Originator & Owner
Collaborator
Technology Provider
Licensee
Highest Development Phase
Indications
Class
Mechanism of Action
ATC Code
Designated Brand Name